Oklahoma 2025 Regular Session

Oklahoma Senate Bill SB331 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2		-	~~SB331 HFLR Page 1~~
3		-	~~BOLD FACE denotes Committee Amendments.~~ 1
	2	+
	3	+	ENGR. S. B. NO. 331 Page 1 1
4	4		2
5	5		3
6	6		4
7	7		5
8	8		6
9	9		7
10	10		8
11	11		9
12	12		10
13	13		11
14	14		12
15	15		13
16	16		14
17	17		15
18	18		16
19	19		17
20	20		18
21	21		19
22	22		20
23	23		21
24	24		22
25	25		23
26	26		24
27		-
28		-	HOUSE OF REPRESENTATIVES - FLOOR VERSION
29		-
30		-	STATE OF OKLAHOMA
31		-
32		-	1st Session of the 60th Legislature (2025)
33	27
34	28		ENGROSSED SENATE
35	29		BILL NO. 331 By: Hines of the Senate
36	30
37	31		and
38	32
39	33		Stinson of the House
40	34
41	35
42	36
43	37
44	38		An Act relating to schools; creating the Emerson Kate
45	39		Cole Act; providing short title; amending 70 O.S.
46	40		2021, Section 1-116.3, which relates to school
47	41		medication policies; updating statutory language;
48	42		updating statutory reference; requiring a school
49	43		employee to call 911 if Epinephrine is administered
50	44		to a student; requiring notification of a parent or
51	45		legal guardian if a student experiences a possible
52	46		allergic reaction; requiring annual training for
53	47		certain teachers and school employees; providing for
54	48		content and method of training; providing for
55	49		noncodification; providing an effective date; and
56	50		declaring an emergency.
57	51
58	52
59	53
60	54
61	55
62	56		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OK LAHOMA:
63	57		SECTION 1. NEW LAW A new section of law not to be
64	58		codified in the Oklahoma Statutes reads as follows:
65	59		This act shall be known and may be cited as the “Emerson Kate
66	60		Cole Act”.
67	61		SECTION 2. AMENDATORY 7 0 O.S. 2021, Section 1 -116.3, is
68	62		amended to read as follows:
69		-	SB331 HFLR Page 2
70		-	BOLD FACE denotes Committee Amendments. 1
	63	+	Section 1-116.3. A. Notwithstanding the provisions of Section
	64	+	1-116.2 of this title, the board of education of each school
	65	+	district shall adopt a policy on or before September 1, 2008, that
	66	+
	67	+	ENGR. S. B. NO. 331 Page 2 1
71	68		2
72	69		3
73	70		4
74	71		5
75	72		6
76	73		7
77	74		8
78	75		9
79	76		10
80	77		11
81	78		12
82	79		13
83	80		14
84	81		15
85	82		16
86	83		17
87	84		18
88	85		19
89	86		20
90	87		21
91	88		22
92	89		23
93	90		24
94	91
95		-	Section 1-116.3. A. Notwithstanding the provisions of Section
96		-	1-116.2 of this title, the board of education of each school
97		-	district shall adopt a policy on or before September 1, 2008, that
98	92		permits the self-administration of inhaled asthma medication by a
99	93		student for treatment of asthma, the self -administration of
100	94		anaphylaxis medication by a student for treatment of anaphylaxis ,
101	95		and the self-administration of replacement pancreatic enzymes by a
102	96		student for treatment of cystic fibrosis. The policy shall require:
103	97		1. The parent or legal guardian of the student to authorize in
104	98		writing the student’s self-administration of medication;
105	99		2. The parent or legal guardian of the student to provide to
106	100		the school a written statement from the physician treating the
107	101		student that the student has asthma, anaphylaxis , or cystic fibrosis
108	102		and is capable of, and has been instructed in the proper method of,
109	103		self-administration of medication;
110	104		3. The parent or legal guardian of the student to provide to
111	105		the school an emergency supply of the student ’s medication to be
112	106		administered pursuant to the provisions of Section 1 -116.2 of this
113	107		title;
114	108		4. The school district to i nform the parent or legal guardian
115	109		of the student, in writing, that the school district and its
116	110		employees and agents shall incur no liability as a result of any
117	111		injury arising from the self -administration of medication by the
118	112		student; and
119		-	SB331 HFLR Page 3
120		-	BOLD FACE denotes Committee Amendments. 1
	113	+	5. The parent or legal guardian of the student to sign a
	114	+	statement acknowledging that the school district shall incur no
	115	+
	116	+	ENGR. S. B. NO. 331 Page 3 1
121	117		2
122	118		3
123	119		4
124	120		5
125	121		6
126	122		7
127	123		8
128	124		9
129	125		10
130	126		11
131	127		12
132	128		13
133	129		14
134	130		15
135	131		16
136	132		17
137	133		18
138	134		19
139	135		20
140	136		21
141	137		22
142	138		23
143	139		24
144	140
145		-	5. The parent or legal guardian of the student to sign a
146		-	statement acknowledging that the school district shall incur no
147	141		liability as a result of any injury arising from the self -
148	142		administration of medication by the student.
149	143		B. The school board of education of each school district that
150	144		elects to stock Epinephrine injectors or inhalers shall amend the
151	145		policy identified in subsection A of this section.
152	146		1. The amended policy for Epinephrine injectors shall require:
153	147		a. the school district to inform the parent or legal
154	148		guardian of each student, in writing, that a school
155	149		nurse or school employee trained by a health care
156	150		professional or trained in correlation with the State
157	151		Department of Health ’s Diabetes Management Annual
158	152		School Training Program annual diabetes management
159	153		training may administer, with parent or legal guardian
160	154		permission but without a health care provider order,
161	155		an Epinephrine injection to a student whom the school
162	156		nurse or trained school employee in good faith
163	157		believes is having an anaphylactic reaction,
164	158		b. a waiver of liability executed by a parent or legal
165	159		guardian to be on file with the school district prior
166	160		to the administration of an Epinephrine injection
167	161		pursuant to subparagraph a of this paragraph 1 of this
168	162		subsection, and
169		-	~~SB331 HFLR Page 4~~
170		-	~~BOLD FACE denotes Committee Amendments.~~ 1
	163	+
	164	+	ENGR. S. B. NO. 331 Page 4 1
171	165		2
172	166		3
173	167		4
174	168		5
175	169		6
176	170		7
177	171		8
178	172		9
179	173		10
180	174		11
181	175		12
182	176		13
183	177		14
184	178		15
185	179		16
186	180		17
187	181		18
188	182		19
189	183		20
190	184		21
191	185		22
192	186		23
193	187		24
194	188
195	189		c. the school district to designat e the employee
196	190		responsible for obtaining the Epineph rine injectors at
197	191		each school site.
198	192		2. The amended policy for inhalers shall require:
199	193		a. the school district to inform the parent or legal
200	194		guardian of each student, in writing, that a school
201	195		nurse or school employee trained by a health care
202	196		professional may administer an inhaler to a student
203	197		whom the school nurse or trained school employee in
204	198		good faith believes is having respiratory distress,
205	199		b. the school district to designate the employee
206	200		responsible for obtaining the inhalers and spacers or
207	201		holding chambers at each school site, and
208	202		c. the school district to notify the parent or legal
209	203		guardian of a student after administration of an
210	204		inhaler.
211	205		C. The school district and its employees and agents shall incur
212	206		no liability as a result of any injury arising pu rsuant to the
213	207		discharge or nondischarge of the powers provided for pursuant to
214	208		subparagraph a of paragraphs 1 and 2 of subsection B of this
215	209		section.
216	210		D. A licensed physician who has prescriptive authority may
217	211		write a prescription for Epinephrine injectors and inhalers and
218	212		spacers or holding chambers to the school district in the name of
219		-	~~SB331 HFLR Page 5~~
220		-	~~BOLD FACE denotes Committee Amendments.~~ 1
	213	+
	214	+	ENGR. S. B. NO. 331 Page 5 1
221	215		2
222	216		3
223	217		4
224	218		5
225	219		6
226	220		7
227	221		8
228	222		9
229	223		10
230	224		11
231	225		12
232	226		13
233	227		14
234	228		15
235	229		16
236	230		17
237	231		18
238	232		19
239	233		20
240	234		21
241	235		22
242	236		23
243	237		24
244	238
245	239		the district as a body corporate specified in Section 5 -105 of this
246	240		title which shall be maintained at each school site. Such physician
247	241		shall incur no liability as a result of any injury arising from the
248	242		use of the Epinephrine injectors or the inhalers and spacers or
249	243		holding chambers.
250	244		E. The school district may maintain at each school a minimum of
251	245		two Epinephrine injectors and two inhalers with spacers or holding
252	246		chambers in a secure location. Provided, however, that nothing in
253	247		this section shall be construed as creating or imposing a duty on a
254	248		school district to maintain Epinephrine injectors or inhalers with
255	249		spacers or holding chambers at a school site or sites.
256	250		F. In the event a student is believed to be having an
257	251		anaphylactic reaction or respiratory distress, a school employee
258	252		shall contact 911 as soon as possible. If Epinephrine is
259	253		administered to a student, a school employee shall contact 911 as
260	254		soon as possible. Th e school district shall notify the parent or
261	255		legal guardian of any student who experiences a possible allergic
262	256		reaction as soon as possible.
263	257		G. The State Board of Education, in consultation with the State
264	258		Board of Health, shall develop model policies whic h school districts
265	259		may use in compliance with this section. The model policies shall
266	260		include, at a minimum, required annual training for teachers and
267	261		school employees who are directly responsible for stu dents on the
268	262		topics of food allergies, recognizing a naphylaxis, and instruction
269		-	~~SB331 HFLR Page 6~~
270		-	~~BOLD FACE denotes Committee Amendments.~~ 1
	263	+
	264	+	ENGR. S. B. NO. 331 Page 6 1
271	265		2
272	266		3
273	267		4
274	268		5
275	269		6
276	270		7
277	271		8
278	272		9
279	273		10
280	274		11
281	275		12
282	276		13
283	277		14
284	278		15
285	279		16
286	280		17
287	281		18
288	282		19
289	283		20
290	284		21
291	285		22
292	286		23
293	287		24
294	288
295	289		on how to administer Epinephrine. The training shall be completed
296	290		before the school year begins or upon hiring the teacher or school
297	291		employee. Documentation certifying completion of the required
298	292		training shall be retained in t he personnel file for the teacher or
299	293		school employee. The training may be provided online or in person
300	294		by the school nurse or a recognized food allergy and anaphylaxis
301	295		training program.
302	296		H. The State Board of Education, in consultation with the State
303	297		Board of Health, shall promulgate rules to implement this section.
304	298		I. As used in this section:
305	299		1. “Medication” means a metered dose inhaler or a dry powder
306	300		inhaler to alleviate asthmatic symptoms, prescribed by a physician
307	301		and having an individual label, an anaphylaxis medication used to
308	302		treat anaphylaxis including but not limited to Epinephrine injectors
309	303		prescribed by a physician and having an individual label, or
310	304		replacement pancreatic enzymes prescribed b y a physician and having
311	305		an individual label; and
312	306		2. “Self-administration” means a student’s use of medication
313	307		pursuant to prescription or written direction from a physician .;
314	308		3. “Respiratory distress ” means the perceived or actual
315	309		presence of coughing, wheezing , or shortness of breath; and
316	310		4. “Inhaler” means a device that delivers a bronchodilator to
317	311		alleviate symptoms of respiratory distress that is manufactured in
318	312		the form of a metered -dose inhaler or dry-powder inhaler and that
319		-	~~SB331 HFLR Page 7~~
320		-	~~BOLD FACE denotes Committee Amendments.~~ 1
	313	+
	314	+	ENGR. S. B. NO. 331 Page 7 1
321	315		2
322	316		3
323	317		4
324	318		5
325	319		6
326	320		7
327	321		8
328	322		9
329	323		10
330	324		11
331	325		12
332	326		13
333	327		14
334	328		15
335	329		16
336	330		17
337	331		18
338	332		19
339	333		20
340	334		21
341	335		22
342	336		23
343	337		24
344	338
345	339		may include a spacer o r holding chamber that attaches to the inhaler
346	340		to improve the delivery of the bronchodilator.
347	341		J. The permission for self -administration of asthma,
348	342		anaphylaxis, or replacement pancreatic enzyme medication is
349	343		effective for the school year for which it is granted and shall be
350	344		renewed each subsequent school ye ar upon fulfillment of the
351	345		requirements of this section.
352	346		K. A student who is permitted to self -administer asthma,
353	347		anaphylaxis, or replacement pancreatic enzyme medication pursuant to
354	348		this section shall b e permitted to possess and use a prescribed
355	349		inhaler, anaphylaxis medication including but not limited to an
356	350		Epinephrine injector, or replacement pancreatic enzyme medication at
357	351		all times.
358	352		SECTION 3. This act shall become effective July 1, 2025.
359	353		SECTION 4. It being immediate ly necessary for the preservation
360	354		of the public peace, health, or safety, an emergency is hereby
361	355		declared to exist, by reason whereof this act shall take effect and
362	356		be in full force from and after its pas sage and approval.
363	357
364		-	COMMITTEE REPORT BY: COMMITTEE ON EDUCATION, dated 04/16/2025 – DO
365		-	PASS.
	358	+	ENGR. S. B. NO. 331 Page 8 1
	359	+	2
	360	+	3
	361	+	4
	362	+	5
	363	+	6
	364	+	7
	365	+	8
	366	+	9
	367	+	10
	368	+	11
	369	+	12
	370	+	13
	371	+	14
	372	+	15
	373	+	16
	374	+	17
	375	+	18
	376	+	19
	377	+	20
	378	+	21
	379	+	22
	380	+	23
	381	+	24
	382	+
	383	+	Passed the Senate the 4th day of March, 2025.
	384	+
	385	+
	386	+
	387	+	Presiding Officer of the Senate
	388	+
	389	+
	390	+	Passed the House of Representatives the ____ day of __________,
	391	+	2025.
	392	+
	393	+
	394	+
	395	+	Presiding Officer of the House
	396	+	of Representatives
	397	+